Bioluminescent Multi-Characteristic Opsin for simultaneous optical stimulation and large-scale monitoring of the visual system

生物发光多特征视蛋白，用于同时进行光学刺激和大规模视觉系统监测

• 批准号: 10433927
• 负责人: Samarendra Kumar Mohanty
• 金额: $ 37.59万
• 依托单位: NANOSCOPE TECHNOLOGIES, LLC
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-09-30 至 2023-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10433927
• 关键词: Address; Behavior; Behavioral; Behavioral Assay; Biological Assay; Bioluminescence; Biomedical Engineering; Biophysics; Blindness; Calcium; Cells; Characteristics; Clinical; Clinical Trials; Collaborations; Degenerative Disorder; Detection; Development; Devices; Disease Progression; Electric Stimulation; Electrophysiology (science); Engineering; Eye; Fluorescence; Goals; Head; Image; Imaging Device; Implant; Individual; Knowledge; Light; Longitudinal Studies; Maps; Measurement; Measures; Membrane; Methods; Molecular Biology; Monitor; Mus; Nervous system structure; Neurons; Nonexudative age-related macular degeneration; Ocular Prosthesis; Ophthalmology; Opsin; Optics; Photic Stimulation; Photophobia; Photoreceptors; Photosensitivity; Photosensitization; Phototoxicity; Research Personnel; Resolution; Retina; Retinal Degeneration; Retinal Photoreceptors; Scientist; Slice; Source; System; Techniques; Technology; Visual; Visual Cortex; Visual system structure; area striata; base; bioluminescence imaging; detector; efficacy evaluation; experience; fluorescence imaging; ganglion cell; implantation; in vivo; innovation; intravitreal injection; mouse model; multidisciplinary; nanoscope; optogenetics; photonics; photoreceptor degeneration; preclinical study; relating to nervous system; response; restoration; retinal imaging; retinal neuron; retinal stimulation; sight restoration; signal processing; stem cells; success; temporal measurement; tool; voltage

The optogenetic stimulation strategy, which is an alternative to electrical stimulation and now under clinical trial for vision restoration in retinal degenerative diseases, involves simple intravitreal injection of safe AAV-carrying opsin to photosensitize higher order retinal neurons. Compared with other strategies, optogenetic method is cell-specific and provides higher resolution. Our optogenetic studies in dry-AMD mice model suggests that degenerated retina can be made highly photosensitive, enabling vision restoration at low light level. Furthermore, our preclinical studies have shown that the visually guided behavior deteriorated with progressive degeneration, which recovered to more non-degenerated level after optogenetic treatment. Though primary visual cortex is known to maintain its retinotopy in subjects with retinal degeneration despite prolonged visual loss, detailed knowledge of how optogenetic sensitization of higher order neurons manifests in restoration of visual cortical activity is currently lacking. Thus, there is a need for mapping changes in the visual cortical activities as progression of retinal degeneration and subsequent vision restoration by optogenetic sensitization of retina occurs. The goal of this study is to develop and characterize tools for simultaneous optical modulation and imaging of retinal and cortical activities using spectrally-separated activation and detection channels. To address this goal, we propose to use newly developed voltage-sensitive bioluminescence assay instead of fluorescence in order to allow simultaneous long-term cortical imaging upon visual stimulation using multi- characteristic opsin (MCO). This will enable us to modulate neural activity in retina and image visual cortex with high temporal and spatial resolution, providing details about disease progression and restoration. The innovativeness of our proposal includes bioluminescent membrane voltage indicator to measure neural activity in long-term studies with high temporal resolution. This new bioluminescent technique does not require an additional potentially phototoxic external excitation source (as used for fluorescence). Further innovativeness includes simultaneous measurements of cortical activities and behavior in response to visual stimulation during retinal degeneration and vision restoration. Towards this goal we will: (i) Demonstrate functioning of Bioluminescent MCO and hardware for stimulation and bioluminescent neural activity monitoring; (ii) Quantify changes in visual cortical activities during progression of retinal photoreceptor degeneration by bMCO using head-mountable sCMOS-camera; and (iii) Evaluate restoration of visual cortical activities upon re- photosensitization of degenerated retina by intravitreal injection of MCO. Success of this proposal will lead to development of a modular and scalable interface system with the capability to serve a multiplicity of applications to modulate and monitor large-scale activity in the nervous system. In the long term, we aim to demonstrate a clinically viable optical stimulation device that can reliably provide stimulation inputs to the visual cortex and simultaneous recording of cortical activities.

光遗传刺激策略，这是电刺激的替代方案，目前正在进行临床试验 对于视网膜退行性疾病的视力恢复，包括简单的玻璃体内注射安全携带AAV 视蛋白使高级视网膜神经元变得光敏。与其他策略相比，光遗传方法是 特定于细胞，提供更高的分辨率。我们在干性AMD小鼠模型上的光遗传学研究表明 退化的视网膜可以变得高度感光，能够在弱光下恢复视力。 此外，我们的临床前研究表明，视觉引导行为随着进展而恶化。 变性，经过光遗传治疗后恢复到更未退化的水平。虽然是主要的 众所周知，尽管视力延长，但视网膜变性受试者的视皮层仍能维持其视网膜病变。 丢失，详细了解高阶神经元的光遗传敏化如何在修复中表现出来 视觉皮质活动目前缺乏。因此，需要映射视觉皮质中的变化 视网膜变性进展和随后通过光遗传敏化恢复视力的活动 发生在视网膜上。这项研究的目标是开发和表征用于同时光学调制的工具 以及使用光谱分离的激活和检测通道对视网膜和皮质活动进行成像。至 为了实现这一目标，我们建议使用新开发的电压敏感生物发光分析来代替 荧光，以允许在视觉刺激时同时进行长期皮质成像 特征视蛋白(MCO)。这将使我们能够调节视网膜和图像视觉皮质的神经活动。 具有高时间和空间分辨率，提供有关疾病进展和恢复的详细信息。这个 我们的方案的创新之处包括生物发光膜电压指示器来测量神经活动 在具有高时间分辨率的长期研究中。这种新的生物发光技术不需要 额外的潜在光毒性外部激发源(用于荧光)。进一步创新 包括同时测量大脑皮质活动和行为对视觉刺激的反应 视网膜变性和视力恢复。为了实现这一目标，我们将：(I)展示 生物发光MCO和用于刺激和生物发光神经活动监测的硬件；(Ii)量化 BMCO诱导视网膜光感受器退行性变过程中视皮质活动的变化 头戴式cmos摄像机；以及(Iii)评估重新检查后视觉皮质活动的恢复情况。 玻璃体内注射MCO对变性视网膜的光敏化作用这项提议的成功将导致 开发模块化和可扩展的接口系统，能够服务于多种 调节和监测神经系统大规模活动的应用。长远来说，我们的目标是 展示一种临床上可行的光学刺激设备，该设备可以可靠地向 视觉皮质和皮质活动的同步记录。